WHO APPROVES CHINA'S SINOPHARM COVID 19 VACCINE EMERGENCY USE

  • 08/05/2021

Sinopharm, the COVID-19 vaccine developed by china receivesThe World Health Organization's(WHO) approval for emergency use.  The WHO has reported that compared to other vaccines, Sinopharm does not require complicated storage requirements. This ensures the viability of the vaccine in difficult terrains and areas with limited infrastructure. 

The vaccine also carries a sticker on the dose that changes color when exposed to heat, helping the handlers to know the usability of the vaccine. WHO recommends the vaccine for people over the age of 18 years, and two doses 3 to 4 weeks apart.

Related News